Table 2. Characteristics of 496 pneumonia patients tested for Acanthamoeba polyphaga mimivirus DNA*.
| Setting or population | Sample size | Age group | Sample type | Location | Period | Other causes |
|---|---|---|---|---|---|---|
| Community-acquired pneumonia cases | 124 | Children<5 y | Nasal swabs | Urban USA | Oct 2000– Sep 2001 | None detected |
| 120 | Adults, children | NP swabs | Rural Thailand | Sep 2003– Aug 2004 | None detected | |
| Nosocomially acquired pneumonia outbreaks | 23 | Geriatric | NP/OP swabs | Retirement center, USA | Sep 2003 | 20% rhinovirus |
| 24 | Geriatric | NP/OP swabs | Retirement center, USA | Jul–Aug 2002 | 20% rhinovirus | |
| 24 | Geriatric | Nasal swabs | Retirement center, USA | May 2004 | 50% hMPV | |
| Community-acquired pneumonia outbreak | 5 | Adults, children | BAL, sputum, ET aspirate | Familial cluster, USA | Nov 2004 | None detected |
| Bone marrow transplant recipients | 42 | Adults | NP aspirate | USA | Jan–Apr 2001 | 60% other respiratory viruses |
| 45 | Adults | Nasal wash, NP swabs | USA | 2003 | 10% influenza and picornaviruses | |
| Lung transplant recipients | 89 | Adults | NP swabs | Canada | 2002–2003 | 30% other respiratory viruses |
*NP, nasopharyngeal; OP, oropharyngeal; hMPV, human metapneumovirus; BAL, bronchoalveolar lavage; ET, endotracheal.